156 related articles for article (PubMed ID: 22426659)
1. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease.
Andican G; Konukoglu D; Bozluolcay M; Bayülkem K; Firtiına S; Burcak G
Acta Neurol Belg; 2012 Jun; 112(2):155-9. PubMed ID: 22426659
[TBL] [Abstract][Full Text] [Related]
2. Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson's disease? A comparison of Parkinson's disease patients, disease controls and healthy individuals.
Song IU; Kim JS; Chung SW; Lee KS
Eur Neurol; 2009; 62(2):99-104. PubMed ID: 19521085
[TBL] [Abstract][Full Text] [Related]
3. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris.
Doo YC; Han SJ; Lee JH; Cho GY; Hong KS; Han KR; Lee NH; Oh DJ; Ryu KH; Rhim CY; Lee KH; Lee Y
Am J Cardiol; 2004 Mar; 93(5):554-8. PubMed ID: 14996578
[TBL] [Abstract][Full Text] [Related]
4. Oxidative damage in Parkinson disease: Measurement using accurate biomarkers.
Seet RC; Lee CY; Lim EC; Tan JJ; Quek AM; Chong WL; Looi WF; Huang SH; Wang H; Chan YH; Halliwell B
Free Radic Biol Med; 2010 Feb; 48(4):560-6. PubMed ID: 19969070
[TBL] [Abstract][Full Text] [Related]
5. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
White M; Ducharme A; Ibrahim R; Whittom L; Lavoie J; Guertin MC; Racine N; He Y; Yao G; Rouleau JL; Schiffrin EL; Touyz RM
Clin Sci (Lond); 2006 Apr; 110(4):483-9. PubMed ID: 16402915
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.
Zhang YC; Wei JJ; Wang F; Chen MT; Zhang MZ
Cell Biochem Biophys; 2012 Mar; 62(2):365-72. PubMed ID: 21947962
[TBL] [Abstract][Full Text] [Related]
7. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension.
Tousoulis D; Zisimos K; Antoniades C; Stefanadi E; Siasos G; Tsioufis C; Papageorgiou N; Vavouranakis E; Vlachopoulos C; Stefanadis C
Int J Cardiol; 2009 Aug; 136(3):258-62. PubMed ID: 18657327
[TBL] [Abstract][Full Text] [Related]
9. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
Pawlak K; Mysliwiec M; Pawlak D
Life Sci; 2013 Mar; 92(4-5):253-8. PubMed ID: 23295961
[TBL] [Abstract][Full Text] [Related]
10. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood markers of oxidative stress in Parkinson's disease.
Younes-Mhenni S; Frih-Ayed M; Kerkeni A; Bost M; Chazot G
Eur Neurol; 2007; 58(2):78-83. PubMed ID: 17565220
[TBL] [Abstract][Full Text] [Related]
12. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease.
Baran A; Bulut M; Kaya MC; Demirpençe Ö; Sevim B; Akıl E; Varol S
Neurol Sci; 2019 Jan; 40(1):167-173. PubMed ID: 30353300
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte vitamin C levels as potential biomarker for progression of Parkinson's disease.
Ide K; Yamada H; Umegaki K; Mizuno K; Kawakami N; Hagiwara Y; Matsumoto M; Yoshida H; Kim K; Shiosaki E; Yokochi T; Harada K
Nutrition; 2015 Feb; 31(2):406-8. PubMed ID: 25592020
[TBL] [Abstract][Full Text] [Related]
15. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys.
Miklossy J; Doudet DD; Schwab C; Yu S; McGeer EG; McGeer PL
Exp Neurol; 2006 Feb; 197(2):275-83. PubMed ID: 16336966
[TBL] [Abstract][Full Text] [Related]
16. Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease.
Umemura A; Oeda T; Yamamoto K; Tomita S; Kohsaka M; Park K; Sugiyama H; Sawada H
PLoS One; 2015; 10(8):e0136722. PubMed ID: 26308525
[TBL] [Abstract][Full Text] [Related]
17. Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis.
Côté N; Pibarot P; Pépin A; Fournier D; Audet A; Arsenault B; Couture C; Poirier P; Després JP; Mathieu P
Int J Cardiol; 2010 Dec; 145(3):444-9. PubMed ID: 19525020
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress markers are increased since early stages of infection in syphilitic patients.
Hébert-Schuster M; Borderie D; Grange PA; Lemarechal H; Kavian-Tessler N; Batteux F; Dupin N
Arch Dermatol Res; 2012 Nov; 304(9):689-97. PubMed ID: 23011658
[TBL] [Abstract][Full Text] [Related]
19. Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease.
Chen CM; Liu JL; Wu YR; Chen YC; Cheng HS; Cheng ML; Chiu DT
Neurobiol Dis; 2009 Mar; 33(3):429-35. PubMed ID: 19110057
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa.
Agil A; Durán R; Barrero F; Morales B; Araúzo M; Alba F; Miranda MT; Prieto I; Ramírez M; Vives F
J Neurol Sci; 2006 Jan; 240(1-2):31-6. PubMed ID: 16219327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
